SEC 13F Intelligence

Viking Global Investors LP / MRNA

Viking Global Investors LP’s Moderna Inc Position

Does Viking Global Investors LP own Moderna Inc (MRNA)? Not currently — the last reported position was 994.9K shares worth $30M in Q1 2020; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$30M
Q1 2020
Shares
994.9K
% of Portfolio
+0.16%
Quarters Held
6
position exited

Position History MRNA

Reported value by quarter
Q4 ’18: $261MQ4 ’18Q1 ’19: $339MQ1 ’19Q2 ’19: $120MQ2 ’19Q3 ’19: $74MQ3 ’19Q4 ’19: $65MQ4 ’19Q1 ’20: $30MQ1 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2020994.9K$30M+0.16%
Q4 20193.32M$65M+0.30%
Q3 20194.68M$74M+0.39%
Q2 20198.20M$120M+0.54%
Q1 201916.67M$339M+1.95%
Q4 201817.08M$261M+1.48%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Viking Global Investors LP’s full portfolio or all institutional holders of MRNA.